Skip to content

Research on the Mechanism of Ultra-brief Pulse Modified Electroconvulsive Therapy Based on Cognitive Improvement

Research on the Mechanism of Ultra-brief Pulse Modified Electroconvulsive Therapy Based on Cognitive Improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091601
Enrollment
Unknown
Registered
2024-10-31
Start date
2024-09-16
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

ultra-brief pulse group:ultra-brief pulse modified electroconvulsive therapy
brief pulse group:brief pulse modified electroconvulsive therapy

Sponsors

Nanjing Brain Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1.age 18~55 years, able to understand survey instructions and execute cognitive tests; right-handed; 2.the International Classification of Diseases, Tenth Edition-based diagnosis of schizophrenia; 3.clinically indicated ECT, including the treatment of severe psychomotor excitement or retardation, suicide attempts, aggressive behavior, pharmacotherapy intolerance, and ineffectiveness of antipsychotics, as assessed by two attending doctors; 4.The Brief Psychiatric Rating Scale score = 35; 5.patients who provided written informed consent for participating in the study and publication of case series;

Exclusion criteria

Exclusion criteria: 1.modified electroconvulsive therapy in the last 3 months; 2.drug or alcohol abuse or dependence in the last 6 months; 3.Contraindications for MECT exist, or there are severe physical illnesses such as stroke, heart failure, liver failure, cancer, or immune deficiencies. 4.MECT might impact the treatment efficacy or the participants’ safety; 5.Pregnant or breastfeeding women, or those planning to conceive during the study period. 6.Having metal implants such as dentures, pacemakers, or internal hearing aids. 7.other conditions that investigators considered inappropriate for participation in this trial (for example, participating in other clinical trials);

Design outcomes

Primary

MeasureTime frame
MATRICS Consensus Cognitive Battery;autobiographical memory test;

Secondary

MeasureTime frame
The Brief Psychiatric Rating Scale score;N-acetyl-aspartate;choline;myo-inositol;creatinine;inducible forms of the enzyme nitric oxide synthase;homocysteine;prolactin;

Countries

China

Contacts

Public ContactYuxiu Sui

Nanjing Brain Hospital

suiyuxiu@aliyun.com+86 13815895546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026